TD Cowen Maintains Buy on Arteris, Raises Price Target to $40
Rosenblatt Maintains Buy on Arteris, Raises Price Target to $38
Arteris Inc (NASDAQ:AIP) Beats Q1 Estimates and Guides Higher Amid Accelerating AI Chip Demand
Arteris, Inc. (AIP) Q1 2026 Earnings Call Transcript
Full Transcript: Arteris Q1 2026 Earnings Call
Arteris Stock Surges After Q1 Earnings Exceed Expectations
Arteris, Inc. 2026 Q1 - Results - Earnings Call Presentation
Arteris CFO Nicholas B. Hawkins To Retire, Effective Aug. 31
Arteris Raises FY2026 Sales Guidance From $89.000M-$93.000M to $91.000M-$95.000M vs $91.014M Est
Arteris Sees Q2 Sales $23.000M-$24.000M vs $22.000M Est
Arteris Q1 Adj. EPS $(0.03) Beats $(0.07) Estimate, Sales $22.936M Beat $21.030M Estimate
Arteris Inc (NASDAQ:AIP) Fits the Minervini Trend Template with High Growth Momentum
Reported Earlier, Arteris Network-On-Chip Technology Surpasses 4B Global Chip And Chiplet Deployments Driven By Rising AI-Enabled Systems Adoption
Arteris Inc (NASDAQ:AIP) Surpasses Q4 Revenue Estimates, Stock Rises on Strong Guidance
Which stocks are moving after the closing bell on Thursday?
Arteris, Inc. 2025 Q4 - Results - Earnings Call Presentation
Arteris, Inc. (AIP) Q4 2025 Earnings Call Transcript
Arteris Network-On-Chip Reaches 4B Chip Deployment Milestone
Arteris shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 and Q1 sales guidance above estimates.
Arteris Sees Q1 Sales $20.500M-$21.500M vs $18.995M Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.